Dr Reddy’s, Hetero sign voluntary licenses with Gilead for HIV drug | Company News
4 min read Last Updated : Oct 02 2024 | 9:34 PM IST Hyderabad-based Hetero and Dr Reddy’s Laboratories have signed a non-exclusive, royalty-free voluntary licensing agreement with Gilead Sciences Ireland UC to manufacture and distribute lenacapavir, a breakthrough HIV treatment drug, in 120 primarily low- and lower-middle-income countries (LMICs), including India. Lenacapavir … Read more